NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry Sells 3,000 Shares

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the firm’s stock in a transaction dated Friday, December 20th. The stock was sold at an average price of $4.64, for a total value of $13,920.00. Following the completion of the transaction, the director now directly owns 144,553 shares in the company, valued at $670,725.92. The trade was a 2.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

NEXGEL Price Performance

Shares of NASDAQ:NXGL opened at $4.74 on Wednesday. The company has a quick ratio of 0.93, a current ratio of 1.51 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $32.19 million, a PE ratio of -8.17 and a beta of 0.76. The firm’s 50 day moving average price is $3.45 and its 200-day moving average price is $2.85. NEXGEL, Inc. has a twelve month low of $1.84 and a twelve month high of $5.10.

Institutional Inflows and Outflows

An institutional investor recently raised its position in NEXGEL stock. Northeast Financial Group Inc. increased its stake in NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 31,848 shares of the company’s stock after purchasing an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned approximately 0.50% of NEXGEL worth $82,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 2.21% of the company’s stock.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.